The CVS contract extension removes a key overhang on Cardinal's revenue visibility through 2032, but the reaffirmed guidance suggests no incremental margin upside from the deal. Watch the November 5 Q1 earnings call for any updated FY2027 guidance or commentary on distribution margin trends.
Price Chart
Executive Summary
Cardinal Health entered a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032, maintaining the current scope of services. The company also reaffirmed its FY2027 non-GAAP EPS guidance of $12.40-$12.60 (12-14% long-term growth) and its long-term growth target. This secures a major revenue stream for nearly six more years but provides no new financial upside vs. prior guidance.
Key Facts
- Binding letter of intent to extend CVS Health pharmaceutical distribution agreements through June 30, 2032
- Current scope of distribution services unchanged
- FY2027 non-GAAP EPS guidance reaffirmed at $12.40-$12.60 (13%-15% growth vs adjusted FY2026)
- Long-term non-GAAP EPS growth rate guidance reaffirmed at 12%-14%
- Next update expected during Q1 FY2027 earnings call on November 5, 2026
Financial Impact
No new financial figures disclosed; existing FY2027 non-GAAP EPS guidance of $12.40-$12.60 reaffirmed
Risk Factors
- Binding letter of intent may still be subject to final definitive agreement terms
- No financial terms of the extension disclosed — margin structure unknown
- CVS Health could face regulatory or competitive pressures that alter future volume
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000721371-26-000041 |
| Document: draftcvsloi101v4.htm | 0000721371-26-000041 |
| Document: 0000721371-26-000041-index-headers.html | 0000721371-26-000041 |
| Document: 0000721371-26-000041-index.html | 0000721371-26-000041 |
| Document: 0000721371-26-000041.txt | 0000721371-26-000041 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Institutional Cluster | $250.39 | awaiting T+20 | — | $251.54 (+0.46%) |
Oct 27, 2026 1d ago | GOVT-CONTRACT | $250.39 | awaiting T+20 | — | $251.54 (+0.46%) |
Oct 27, 2026 1d ago | GOVT-CONTRACT | $250.39 | awaiting T+20 | — | $251.54 (+0.46%) |
Oct 27, 2026 1d ago | GOVT-CONTRACT | $250.39 | awaiting T+20 | — | $251.54 (+0.46%) |
Oct 1, 2026 26d ago | 8-K | $230.09 | awaiting T+20 | — | $251.54 (+9.32%) |
Oct 1, 2026 26d ago | Press Release | $230.09 | awaiting T+20 | — | $251.54 (+9.32%) |
Aug 20, 2026 9w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $251.54 (+10.10%) |
Aug 20, 2026 9w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $251.54 (+10.10%) |
Aug 20, 2026 9w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $251.54 (+10.10%) |
Aug 11, 2026 11w ago | 8-K | $240.26 $239.92 | ▼ −0.14% | ▲ +0.92% | $251.54 (+4.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers